Vaccines and antivirals are the classical weapons deployed to contain, prevent, and treat life-
threatening viral illnesses. Specifically, for SARS-CoV-2 infection, vaccines protect against …

The research and development of non-viral gene therapy has been extensive over the past
decade and has received a big push thanks to the recent successful approval of non-viral …

Up to half of individuals who contract SARS-CoV-2 develop symptoms of long-COVID
approximately three months after initial infection. These symptoms are highly variable, and …

Simple Summary The world has been stricken mentally, physically, and economically by the
COVID-19 virus. However, while SARS-CoV-2 viral infection results in mild flu-like symptoms …

Despite the protracted battle against coronavirus acute respiratory infection (COVID-19) and
the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Objectives To determine predictors of high-flow nasal cannula (HFNC) failure in COVID-19
patients in a hospital in northern Peru. Methodology A retrospective cohort study was …

Despite the availability of effective vaccines against COVID-19, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide, pressing the need …

Up to half of individuals who contract SARS-CoV-2 develop symptoms of long-COVID
approximately three months after initial infection. These symptoms are highly variable, and …

Materials and Methods: We followed the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines and searched scientific sites related to our review …

There have been significant collaborative efforts over the past three years to develop
therapies against COVID-19. During this journey, there has also been a lot of focus on …